User profiles for A. Rouette
Alexandre RouettePhD candidate at the Institute of Immunology and Cancer, University of Montreal Verified email at umontreal.ca Cited by 138 |
[PDF][PDF] The evolutionary landscape of localized prostate cancers drives clinical aggression
…, J Wintersinger, F Yousif, E Lalonde, A Rouette… - Cell, 2018 - cell.com
The majority of newly diagnosed prostate cancers are slow growing, with a long natural life
history. Yet a subset can metastasize with lethal consequences. We reconstructed the …
history. Yet a subset can metastasize with lethal consequences. We reconstructed the …
A robust benchmark for detection of germline large deletions and insertions
…, SME Sahraeian, V Huang, A Rouette… - Nature …, 2020 - nature.com
New technologies and analysis methods are enabling genomic structural variants (SVs) to
be detected with ever-increasing accuracy, resolution and comprehensiveness. To help …
be detected with ever-increasing accuracy, resolution and comprehensiveness. To help …
[HTML][HTML] Expression of immunoproteasome genes is regulated by cell-intrinsic and–extrinsic factors in human cancers
A Rouette, A Trofimov, D Haberl, G Boucher… - Scientific reports, 2016 - nature.com
Based on transcriptomic analyses of thousands of samples from The Cancer Genome Atlas,
we report that expression of constitutive proteasome (CP) genes (PSMB5, PSMB6, PSMB7) …
we report that expression of constitutive proteasome (CP) genes (PSMB5, PSMB6, PSMB7) …
Genome-wide germline correlates of the epigenetic landscape of prostate cancer
…, LE Heisler, J Livingstone, TN Yamaguchi, A Rouette… - Nature medicine, 2019 - nature.com
Oncogenesis is driven by germline, environmental and stochastic factors. It is unknown how
these interact to produce the molecular phenotypes of tumors. We therefore quantified the …
these interact to produce the molecular phenotypes of tumors. We therefore quantified the …
A robust benchmark for germline structural variant detection
New technologies and analysis methods are enabling genomic structural variants (SVs) to
be detected with ever-increasing accuracy, resolution, and comprehensiveness. Translating …
be detected with ever-increasing accuracy, resolution, and comprehensiveness. Translating …
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
…, N El-Hachem, V Lisi, B Khakipoor, A Rouette… - Blood …, 2024 - ashpublications.org
Acute megakaryoblastic leukemia (AMKL) is a rare, developmentally restricted, and highly
lethal cancer of early childhood. The paucity and hypocellularity (due to myelofibrosis) of …
lethal cancer of early childhood. The paucity and hypocellularity (due to myelofibrosis) of …
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities
…, L Aubert, T Milan, L Jouan, A Rouette… - Blood …, 2019 - ashpublications.org
Acute megakaryoblastic leukemia (AMKL) represents ∼10% of pediatric acute myeloid
leukemia cases and typically affects young children (<3 years of age). It remains plagued with …
leukemia cases and typically affects young children (<3 years of age). It remains plagued with …
Immunoproteasomes shape the transcriptome and regulate the function of dendritic cells
By regulating protein degradation, constitutive proteasomes (CPs) control practically all cellular
functions. In addition to CPs, vertebrates express immunoproteasomes (IPs). The major …
functions. In addition to CPs, vertebrates express immunoproteasomes (IPs). The major …
PSMB11 orchestrates the development of CD4 and CD8 thymocytes via regulation of gene expression in cortical thymic epithelial cells
A Apavaloaei, S Brochu, M Dong, A Rouette… - The Journal of …, 2019 - journals.aai.org
T cell development depends on sequential interactions of thymocytes with cortical thymic
epithelial cells (cTECs) and medullary thymic epithelial cells. PSMB11 is a catalytic …
epithelial cells (cTECs) and medullary thymic epithelial cells. PSMB11 is a catalytic …
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
…, M Caron, P Saint-Onge, A Rouette… - Blood …, 2022 - ashpublications.org
The molecular hallmark of childhood acute lymphoblastic leukemia (ALL) is characterized
by recurrent, prognostic genetic alterations, many of which are cryptic by conventional …
by recurrent, prognostic genetic alterations, many of which are cryptic by conventional …